company background image
IPA

ImmunoPrecise Antibodies NasdaqGM:IPA Stock Report

Last Price

US$4.44

Market Cap

US$110.6m

7D

0.8%

1Y

-20.1%

Updated

07 Feb, 2023

Data

Company Financials +

ImmunoPrecise Antibodies Ltd.

NasdaqGM:IPA Stock Report

Mkt Cap: US$110.6m

IPA Stock Overview

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally.

IPA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

New

Notes are coming soon

ImmunoPrecise Antibodies Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ImmunoPrecise Antibodies
Historical stock prices
Current Share PriceUS$4.44
52 Week HighUS$6.50
52 Week LowUS$3.51
Beta0.57
1 Month Change-14.38%
3 Month Change-11.83%
1 Year Change-20.09%
3 Year Change86.85%
5 Year Change164.46%
Change since IPO2.21%

Recent News & Updates

ImmunoPrecise Antibodies reports FQ1 results

Sep 14

Recent updates

ImmunoPrecise Antibodies reports FQ1 results

Sep 14

ImmunoPrecise’s polytope program reduces lung inflammation in SARS-CoV-2 challenged hamsters

Jun 17

ImmunoPrecise Antibodies to raise $21.7 via equity offering

Feb 04

Shareholder Returns

IPAUS Life SciencesUS Market
7D0.8%0.6%0.9%
1Y-20.1%-12.5%-10.9%

Return vs Industry: IPA underperformed the US Life Sciences industry which returned -11.2% over the past year.

Return vs Market: IPA underperformed the US Market which returned -9.6% over the past year.

Price Volatility

Is IPA's price volatile compared to industry and market?
IPA volatility
IPA Average Weekly Movement9.3%
Life Sciences Industry Average Movement11.6%
Market Average Movement6.7%
10% most volatile stocks in US Market17.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: IPA is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: IPA's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198385Jennifer Bathhttps://www.ipatherapeutics.com

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation.

ImmunoPrecise Antibodies Ltd. Fundamentals Summary

How do ImmunoPrecise Antibodies's earnings and revenue compare to its market cap?
IPA fundamental statistics
Market CapUS$110.59m
Earnings (TTM)-US$18.75m
Revenue (TTM)US$14.82m

7.5x

P/S Ratio

-5.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
IPA income statement (TTM)
RevenueCA$19.93m
Cost of RevenueCA$8.98m
Gross ProfitCA$10.95m
Other ExpensesCA$36.15m
Earnings-CA$25.20m

Last Reported Earnings

Oct 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.01
Gross Margin54.95%
Net Profit Margin-126.47%
Debt/Equity Ratio0%

How did IPA perform over the long term?

See historical performance and comparison